title: Hydroxychloroquine: a diabetic drug in disguise?
abstract: Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.
authors.affiliation: University of Nebraska Medical Center, General Internal Medicine, MSB 5544, 983331, Omaha, Nebraska, 68198-3331, USA.
authors.forename: Lydia
authors.initials: L
authors.lastname: Kang
authors.forename: Ted R
authors.initials: TR
authors.lastname: Mikuls
authors.forename: James R
authors.initials: JR
authors.lastname: O'Dell